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Purpose: Differentiation of neural stem/progenitor cells involves changes in the gene expression of these cells. Less clear
is the extent to which incremental changes occur and the time course of such changes, particularly in non-rodents.
Methods: Using porcine genome microarrays, we analyzed changes in the expression of 23,256 genes in porcine neural
progenitor cells (pNPCs) subject to two established differentiation protocols. In addition, we performed sequential
quantitative assessment of a defined transcription profile consisting of 15 progenitor- and lineage-associated genes
following exposure to the same treatment protocols, to examine the temporal dynamics of phenotypic changes following
induction  of  differentiation.  Immunocytochemistry  was  also  used  to  examine  the  expression  of  seven  of  these
phenotypically important genes at the protein level. Initial primary isolates were passaged four times in proliferation
medium containing 20 ng/ml epidermal growth factor (EGF) and 20 ng/ml basic fibroblast growth factor (bFGF) before
differentiation was induced. Differentiation was induced by medium without EGF or bFGF and containing either 10 ng/
ml ciliary neurotrophic factor or 10% fetal bovine serum (FBS). Cultures were fed every two days and harvested on days
0, 1, 3, and 5 for quantitative real-time PCR.
Results: The microarray results illustrated and contrasted the global shifts in the porcine transcriptome associated with
both treatment conditions. PCR confirmed dramatic upregulation of transcripts for myelin basic protein (up to 88 fold),
claudin 11 (up to 32 fold), glial fibrillary acidic protein (GFAP; up to 26 fold), together with notable (>twofold) increases
in message for microtubule associated protein 2 (MAP2) and C-X-C chemokine receptor type 4 (CXCR4), Janus kinase 1
(Jak1), signal transducer and activator of transcription 1 (STAT1), and signal transducer and activator of transcription 3
(STAT3). Transcripts for nestin and Krüppel-like factor 4 (KLF4) decreased sharply (>twofold). The specific dynamics
of expression changes varied according to the transcript and treatment condition over the five days examined following
induction. The magnitude of neuronal marker induction was greater for the ciliary neurotrophic factor condition while
glial fibrillary acidic protein induction was greater for the FBS condition.
Conclusions: The transient dynamic of CXCR4 expression during induction of differentiation, as well as the upregulation
of several major histocompatibility complex (MHC) transcripts, has implications in terms of graft integration and
tolerance, respectively. These data confirm and extend in the pig the findings previously reported with murine retinal
progenitors and support the use of this large animal model for translational development of regenerative approaches to
neurologic diseases.
Neural progenitor cells (NPCs) are multipotent, tissue-
specific cells that generate neuronal and glial cell types during
development  of  the  central  nervous  system  [1,2].  As  a
consequence of the pivotal role of NPCs in development, the
regulation of NPC behavior is as elaborate as it is important.
Multiple molecular pathways have been implicated in the
proliferation and differentiation of these cells, and at present,
the  topic  remains  incompletely  understood.  Considerable
effort  has  been  directed  toward  elucidating  NPC
differentiation in vivo using molecular genetic approaches in
the mouse. The insights derived from those studies have been
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quite helpful to workers striving to direct the differentiation
of  pluripotent  stem  cells  into  tissue-specific  lineages;
however, results for cultured multipotent NPCs have been
more  limited.  Nevertheless,  the  in  vitro  differentiation  of
cultured NPCs into neurons and glia remains an important
assay for confirming multipotency and thus the identity of
these cells.
Several methods for achieving NPC differentiation are
commonly used; however, the methods themselves are rarely
compared. For example, serum and mitogen withdrawal are
recognized methods of inducing differentiation of NPCs, but
suffer  from  a  lack  of  specificity  and  poor  viability,
respectively.  Examples  of  specific  molecules  known  to
influence  NPC  activity  include  fibroblast  and  epidermal
growth factors, thyroid hormone [3], cortisol [4], retinoic acid
[5], opioids [6], glutamate [7], as well as a wide range of
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1484neurotrophic factors [8], of which ciliary neurotrophic factor
(CNTF)  has  attracted  repeated  attention  as  a  putative
differentiating agent [9,10].
CNTF  is  a  22-kDa  protein  that  bears  a  familial
relationship  with  leukemia  inhibitory  factor  (LIF)  and
interleukin-6  (IL-6),  all  of  which  share  a  common
amphipathic helical domain. In the central nervous system
(CNS), CNTF is specifically expressed by astrocytes and has
been shown to support the survival of all classes of peripheral
nervous system neurons and many neurons from the CNS as
well. In vitro, this neurotrophic factor has been associated with
the  induction  of  neurite  outgrowth,  promotion  of  the
cholinergic phenotype in sympathetic neurons, and arrest of
cell division in neuronal precursor cells [11,12] with various
influences on the survival and differentiation of embryonic
cells of neuronal and glial lineages [11,12]. In vivo, CNTF
administration has been specifically associated with rescue of
central neurons from axotomy-induced cell death and, under
normal  conditions,  appears  to  play  a  general  role  in
developing  and  maintaining  the  nervous  system  [13–15].
CNTF acts on glial progenitor cells from the neonatal rat optic
nerve, which develop into either oligodendrocytes or type-2
astrocytes following exposure to this molecule [16]. A second
role  of  CNTF  regarding  CNS  glial  cells  is  mitigating
oligodendrocyte  death  in  serum-free  medium  or  upon
exposure to tumor necrosis factor (TNF) [17].
Several major signal transduction pathways have been
linked to neural development, one being activation of the
Janus  tyrosine  kinase/signal  transducer  and  activator  of
transcription  (JAK/STAT)  pathway  by  binding  to
glycoprotein 130 (gp130) [10,18] and others including the
mitogen-activated protein kinase (MAPK) [14,19] and Notch
[20]  pathways.  The  CNTF  receptor  complex  is  known  to
include gp130 as a component and CNTF does signal through
the  JAK/STAT  pathway  [21],  although  signaling  through
additional pathways has also been reported, including the
extracellular  signal-related  kinase  (ERK)  [22],
phosphatidylinositol-3-kinase/AKT [23], MAPK, and Notch
[24] pathways.
A variety of animal models have been used to investigate
the  effect  of  CNTF  on  central  nervous  system  (CNS)
progenitors, including mouse [19,25,26], rat [15,27,28], and
chicken  [29].  Rodent  species  and  chicken  embryos  are
generally  preferred  in  the  laboratory  for  several  reasons,
including availability of species-specific molecular reagents
and relative ease of care and low cost of maintenance. More
recently,  however,  the  pig  has  assumed  an  increasingly
prominent role as a large animal model for treating human
disease [30], and this work has included studies of neural
progenitor cell isolation [31] and transplantation to the retina
[32,33]. The availability of porcine neural progenitor cells
(pNPCs) now allows exploration of cultured NPC behavior in
a large animal model and assessment of the influence of CNTF
on cells of this species.
Genomic  profiling  has  been  used  to  characterize
transcriptional patterns in NPCs in various research models
[32,34,35]. In prior work, we employed conventional PCR,
immunocytochemistry,  flow  cytometry,  and  microarrays
using  human-specific  or  cross-mammalian  reagents  and
probes  to  examine  the  gene  expression  of  pNPCs  [31].
Subsequent  work  by  another  group  used  proteomics  to
examine the differentiation of cells of this type [36]. Recent
progress in sequencing and annotating the porcine genome
now permits the design of improved probes for use in this
species. Here we use porcine DNA microarrays combined
with quantitative real-time PCR and pig-specific primers to
confirm  and  broaden  considerably  our  initial  findings  for
pNPCs in the context of standard proliferation conditions as
well  as  fetal  bovine  serum  (FBS)  and  CNTF-based
differentiation  conditions.  Using  these  methods,  we
demonstrate  global  changes  in  transcription  as  well  as
dynamic  alterations  in  the  expression  patterns  of  relevant
phenotypic markers by cultured porcine NPCs as these cells
transition from proliferative to more differentiated cell types.
METHODS
Donor  animals:  Fetal  pigs  were  harvested  at  45  days
gestational age from a crossbred adult sow under general
anesthesia and the donor terminated without waking. The
process was performed in accordance with the guidelines of
the National Institutes of Health Guide for the care and use of
laboratory  animals  (NIH  Publications  No.  80–23,  revised
1978).
Cell isolation and culture: Fetal pigs were transported to the
laboratory  on  ice  and  dissected  in  a  laminar  flow  hood
approximately 8 h after removal from the maternal donor. The
cranium was opened and the brain removed. Forebrains were
minced mechanically, followed by digestion in 0.05% Trypsin
Express  (Invitrogen,  Carlsbad,  CA)  for  5  min  at  37  °C.
Remaining tissue fragments were gently triturated using a 1 ml
fire-polished glass Pasteur pipette to release single cells, and
this process was repeated for two cycles. The resulting cell
suspension  was  centrifuged  at  1000  rpm  for  5  min  and
resuspended in fresh culture medium comprised of Advanced
Dulbecco's Modified Eagle Medium: Nutrient Mixture F-12
(D-MEM/F12;  Invitrogen)  with  2  mM  GlutaMAX
(Invitrogen,),  N2  supplement  (1%,  Invitrogen),  20  ng/ml
epidermal growth factor (EGF; Invitrogen), 20 ng/ml basic
fibroblast growth factor (bFGF; Invitrogen), and 50 U/ml
penicillin-streptomycin  (Invitrogen).  Cell  viability  was
assessed with trypan blue (Sigma-Aldrich, St. Louis, MO),
and cells were plated in uncoated 75 cm2 flasks at a cell density
of 6.7×104/cm2, followed by incubation at 37 °C under 5%
CO2. Then 5% fetal bovine serum was included in the medium
overnight  to  promote  cellular  viability  and  adherence,
followed by a complete change to serum-free medium the next
day. From that point onward, serum-free medium was used
for culturing NPCs under proliferation conditions. Cells were
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two days and passaged at 80% confluence, every four to five
days, using 0.05% Trypsin Express.
Differentiation conditions for neural progenitor cells: Early
stage, passage-4 pNPCs were used as the starting point for the
differentiation  experiments.  Cells  in  confluent  T75  flasks
were trypsinized and resuspended as a single-cell suspension
(0.5×106/ml), and then seeded into uncoated T75 flasks and
allowed to grow for 48 h at 37 °C in serum-free standard
medium (SM). The standard medium containing EGF and
bFGF was then removed, and the cells were washed with basic
DMEM/F12  medium  without  added  growth  factors.  Cells
were then changed to one of two different differentiation
conditions, neither of which contained EGF or bFGF. These
consisted  of  medium  containing  either  CNTF  (10  ng/ml,
Chemicon,  Temecula,  CA)  [11,12]  or  10%  FBS  (Sigma-
Aldrich).  Controls  were  again  maintained  in  standard
proliferation  medium  containing  EGF  and  bFGF.  For  all
conditions, the medium was replaced twice during the five
continuous days of the experiment. Images of the cultured
cells  were  recorded  using  a  Nikon  inverted  microscope,
ECLIPSE TS100, with a Nikon DXM1200C camera (Nikon
Instruments, Inc., Melville, NY).
RNA  extraction:  Total  RNA  was  extracted  from  three
different groups of cells, the control group (grown in standard
medium containing EGF and bFGF), the CNTF group (not
containing  EGF  and  bFGF),  and  the  FBS  group  (not
containing EGF and bFGF), and the samples were processed
using an RNeasy Mini Kit (Qiagen, Valencia, CA) following
the  manufacturer’s  instructions  for  samples  obtained  at
experimental  day  0,  day  1,  day  3,  and  day  5.  RNA  was
quantified  with  spectrophotometer  (ND-1000;  NanoDrop
Technologies Inc., Wilmington, DE) optical density (OD)
absorption ratio OD260 nm/OD280 nm 2.00–2.10, OD260
nm/OD230 nm 2.00–2.20.
Microarray  analysis:  All  samples  of  total  RNA  from
treatment day 5 were assessed for quality before processing
by transferring a small amount of each sample (100 ng/well)
onto an RNA Lab-on-a-Chip (Caliper Technologies Corp.,
Mountain  View,  CA)  for  evaluation  via  an  Agilent
Bioanalyzer  2100  (Agilent  Technologies,  Palo  Alto,  CA).
Single-stranded,  then  double-stranded  (ds),  cDNA  was
synthesized from the poly(A)+ mRNA present in the isolated
total RNA (5.0 μg total RNA starting material each sample
reaction)  using  the  SuperScript  Double-Stranded  cDNA
Synthesis Kit (Invitrogen) and poly (T)-nucleotide primers
that contained a sequence recognized by T7 RNA polymerase.
A portion of the resulting ds cDNA was used as a template to
generate biotin-tagged cRNA from an in vitro transcription
reaction  (IVT),  using  the  BioArray  HighYield  RNA
Transcript  Labeling  Kit  (T7;  Enzo  Diagnostics,  Inc.,
Farmingdale,  NY).  Approximately  15  μg  of  the  resulting
biotin-tagged cRNA was fragmented to strands of 35–200
bases  long  following  prescribed  protocols  (Affymetrix
GeneChip  Expression  Analysis  Technical  Manual,  Santa
Clara, CA). Subsequently, 10 μg of this fragmented target
cRNA  was  hybridized  at  45  °C  with  rotation  for  16  h
(Affymetrix GeneChip Hybridization Oven 640) to probe sets
present on an Affymetrix GeneChip Porcine Genome Array.
The GeneChip arrays were washed and then stained (SAPE,
streptavidin-phycoerythrin) on an Affymetrix Fluidics Station
450,  followed  by  scanning  on  an  Affymetrix  GeneChip
Scanner  3000  7G.  The  results  were  normalized  with  the
sketch-quantile  method  (Expression  Console  ver.1.1
software,  Affymetrix,  Inc.).  Microarray  data  were  then
evaluated using JMP Genomics 4.1 (SAS Americas, Cary,
NC). The data were analyzed with one-way ANOVA with a
post hoc Student t test and the resulting p-values corrected
using an false discovery rate (FDR) α<0.05 [37]. The resulting
data table was annotated with reference to Tsai et al. [38]. JMP
TABLE 1. PRIMERS USED IN QUANTITATIVE REAL-TIME PCR.
Gene Forward primer (5′-3′) Reverse primer (3′-5′) Product size (bp) Tm °C
β-actin acatcaaggagaagctgtgctac cttcatgatggagttgaaggtagtt 221 60
nestin ggcttctctcagcatcttgg aaggctggcataggtgtgtc 150 60
Sox2 acttttgtcggagacggaga tccgggcagtgtgtacttatc 148 60
vimentin tcaagtgcctttctgcagttt tagcacaaggcttcttcggta 143 60
Ki-67 gaaacccagatccgagcata cagcagctattctggcaaca 139 60
β3-tubulin cagagcaagaacagcagctactt gtgaactccatctcgtccatgccctc 250 60
MAP2 gccatcatacgtactcctcca agagccacatttggatgtcac 198 60
GFAP ttgacctgcgacgtggagtc aggtggcgatctcgatgtcc 225 60
MBP gagatggctcaactcagaacg ggttagtatttgccgtgagca 125 60
Claudin 11 atgctcattctgctggctct gcctgcatacagggagtagc 108 60
KLF4 cagcttcagctatccgatcc tgccttcaacacaaacttgc 256 60
C-myc gcccatgaattcacacttgtt ggatcatgcattcgagaaaaa 123 60
CXCR4 ctgctggctgccatactaca tccaaggaaagcgtagagga 169 60
JAK1 tttgagaagtccgaggtgcta caggatctgcttcttcaggtg 147 60
Stat1 agcaagcgtaaccttcagga gaatctctgggcattttcca 111 60
Stat3 aactcctaggacctggtgtgaa cgctccctctccttactgataa 193 60
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analysis, a Venn diagram, as well as a hierarchical cluster and
heat map, using the default fast Ward’s method, in addition to
volcano plots from the ANOVA results. Hierarchical clusters
were analyzed using Database for Annotation, Visualization
and  Integrated  Discovery  (DAVID)  Bioinformatics
(Laboratory of Immunopathogenesis and Bioinformatics) to
assess the types of genes present within each cluster [39,40].
Only clusters with an enrichment of p<0.05 were analyzed
further.
Real-time  polymerase  chain  reaction  assay:  Selection  of
candidate markers was based on the results of our previous
work with cells of this type, together with potential relevance
to  the  current  study.  Particular  emphasis  was  placed  on
markers associated with immature cells of neural lineage, as
well as selected markers for neural and glial differentiation.
In the present study, we have included markers associated
with oligodendrocyte differentiation. The constraints imposed
by species specificity continue to limit the individual markers
available for work on porcine material.
Two  micrograms  of  total  RNA  from  the  sample
preparation was reverse transcribed with an Omniscriptase
Reverse  Transcriptase  kit  (Qiagen)  and  10  µM  random
primers (Sigma) according to the manufacturer’s instructions.
Real-time PCR was performed using a 7500 Fast Real-Time
PCR System (Applied Biosystems, Irvine, CA) using Power
SYBR Green (Applied Biosystems). Resolution of the product
of  interest  from  non-specific  product  amplification  was
achieved  with  melting  curve  analysis.  The  gene-specific
primers used in this study are shown in Table 1. β-Actin
(ATCB) was used as an endogenous control to normalize gene
expression. The following general real-time PCR protocol
was  used:  denaturation  program  (95  °C  for  10  min),
quantification program (95 °C 15 s and 60 °C 1 min) repeated
40 cycles, melting curve program (95 °C 15 s and 60 °C 1 min
with continuous fluorescence measurements), and finally a
cooling program down to 40 °C. Each reaction was performed
in triplicate. Graphs were plotted, and analysis was performed
with the ΔΔCt method (7500 Fast System software 1.4 and
DataAssist 2.0, Applied Biosystems) and JMP software 4.1
(SAS Americas). All data points are expressed as mean ±
standard  error  (SE).  Statistical  difference  was  determined
using the Student t test. Data were considered significantly
different when p<0.05.
Immunocytochemistry:  Passage-4  pNPCs  were  dissociated
and grown on four-well chamber slides followed by either
CNTF or FBS treatment conditions for 24 h. Cells were then
fixed for 15 min in 4% paraformaldehyde and then washed
three  times  with  PBS,  after  which  a  blocking  solution
consisting of 0.3% Triton X-100 and 5% donkey serum was
applied for 1 h, followed by another PBS wash. A panel of
antibodies was then incubated overnight at 4 °C to detect
antigens  expressed  by  progenitor  cells  before  and  after
treatment with either CNTF or FBS. These included anti-Sox2
(1:400; Santa Cruz Biotechnology Inc., Santa Cruz CA), anti-
Ki-67 (1:400; BD Biosciences, San Jose, CA), anti-β3-tubulin
(1:200;  Chemicon),  anti-Map2  (1:2,000;  Chemicon),  anti-
glial fibrillary acidic protein (anti-GFAP; 1:400; Chemicon),
anti-CXCR4  (1:200;  Santa  Cruz),  and  anti-Klf4  (1:800;
Chemicon).  This  was  followed  by  incubation  with  either
antimouse Alexa 546 (1:400; Invitrogen), antigoat Alexa 488
(1:400; Invitrogen), or antirabbit fluorescein isothiocyanate
(FITC; 1:800; Chemicon) secondary antibodies. Fluorescence
was  detected  using  Leica  converse  microscopy  and
Metamorph  software  (Leica  Microsystems  Inc.,  Buffalo
Grove, IL). Percentage positive profiles were calculated by
counting those profiles expressing specific immunoreactivity
in  six  randomly  selected  fields,  with  4',6-diamidino-2-
phenylindole (DAPI) used to determine the total cell number.
RESULTS
Morphological changes associated with ciliary neurotrophic
factor–  and  fetal  bovine  serum–based  differentiation
conditions: Fetal porcine NPC cultures exhibited evidence of
cell division on day 1, day 3, and day 5 as the monolayer of
cells  spread  out  after  plating  under  standard  proliferation
conditions  (SM),  occasionally  forming  small  adherent
clusters. Upon cessation of EGF and bFGF, in combination
with  exposure  to  either  CNTF  or  FBS,  there  was
morphological  evidence  of  cell  differentiation.  In  CNTF-
treated cultures, this consisted of increasing numbers of cells
with small somata and long, thin processes, whereas in FBS-
treated cultures the cells were larger and exhibited a more
polygonal morphology (Figure 1).
Microarray  analysis:  Three-dimensional  principal
component analysis revealed clustering of triplicate data sets
from each treatment group, together with clear separation
between treatment groups (Figure 2A). The first principal
component  effectively  segregated  the  data  in  terms  of
proliferation  versus  differentiation  conditions.  The  second
principal component clearly resolved the differences between
the CNTF- and FBS-based differentiation conditions. The
third  principal  component  correlated  with  the  variance
between replicates within each treatment group. Of the 24,123
genes  assayed  in  the  porcine  genome,  the  number  with
significant fold-change differences (|fold change| > 2; FDR
α<0.05) was 2,404. The number of genes upregulated under
CNTF-based treatment conditions was 1,144 and the number
downregulated  894,  out  of  2,038  genes  that  met  the
significance criteria for this treatment condition (Figure 2B).
For the FBS-based treatment, 891 were upregulated and 252
downregulated, out of 1,143 genes that met the significance
criteria. The CNTF and FBS treatment groups showed more
genes that were upregulated than downregulated, and CNTF
treatment showed a higher overall change in gene expression
than the FBS group.
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1487Figure 1. The morphology of porcine neural progenitor cells (NPCs) changes with time in culture and treatment condition. A: Phase contrast
image of pNPCs just before the initiation of treatment. B-D: pNPCs maintained under standard proliferation conditions increased in number
with time but did not change appreciably in morphology. E-G: pNPCs cultured under ciliary neurotrophic factor (CNTF) treatment conditions
showed an increasing abundance of small cells with long, thin processes. H-J: pNPCs cultured under fetal bovine serum (FBS) treatment
conditions resulted in larger cells with a greater tendency toward polygonal morphology. Scale bar: 100 µm.
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1488Microarray  data  from  all  conditions  clustered  into  four
hierarchical groups: A heat map and a hierarchical cluster
diagram  were  generated  from  all  genes  with  statistically
significant  changes  in  expression  level,  regardless  of  the
magnitude of fold-change. Data from the 5,666 genes that met
an  FDR  correction  of  α<0.05  were  analyzed  to  reveal
correlations  in  expression  behavior  between  genes  and
treatment groups (Figure 3). From this analysis, four clusters
emerged,  containing  2,794,  1,864,  635,  and  373  genes,
respectively. DAVID analysis was then performed on these
four clusters (Appendix 1). One cluster (shown in blue in
Figure 3) contained major histocompatibility complex (MHC)
class II genes, as well as genes related to transcription, protein
processing, immune response, and three groups related to
synaptic transmission. A separate cluster (shown in green)
contained  genes  related  to  cell  cycle  and  mitosis,  several
metabolic  and  biosynthesis  pathways,  as  well  as  genes
involved in angiogenesis and blood vessel formation. A third
cluster (red) contained MHC class I genes and genes related
to immunity. The smallest cluster (orange) showed only two
significant  categories  from  the  DAVID  analysis,  namely,
small  molecule  transport  and  nicotinamide  adenine
dinucleotide–related metabolism.
The  potential  involvement  of  selected  signaling
pathways,  namely,  Jak/STAT,  Notch,  and  wingless-type
(Wnt),  was  also  investigated  regarding  the  hierarchical
clustering  observed.  The  largest  cluster,  associated  with
differentiation, showed upregulation of genes in all pathways
examined,  with  genes  in  the  Wnt/Frizzled  pathway
particularly well represented. In the cluster associated with
immature cells, genes were downregulated across the same
pathways. Results from the smaller, FBS-related clusters were
more mixed.
Comparison of treatment-induced gene expression changes
using  volcano  plots:  Volcano  plots  were  used  to  further
evaluate global gene expression between treatment groups,
based  on  the  magnitude  and  significance  of  the  changes
induced (Figure 4). Comparison of CNTF-based treatment to
SM  showed  that  more  genes  were  upregulated  than
downregulated  (Figure  4A).  Comparison  of  FBS-based
treatment  to  SM  showed  an  even  greater  proportion  of
upregulated as opposed to downregulated genes (Figure 4B).
Comparison of CNTF- versus FBS-based treatments showed
that a higher number of genes were downregulated following
CNTF-  compared  to  FBS-based  treatment  (Figure  4C).
Another comparison of CNTF- versus FBS-based treatment
conditions  was  performed  in  which  fold  changes  were
compared directly. This comparison also showed a higher
number  of  genes  were  upregulated  in  the  FBS-based
treatment, compared to CNTF-based treatment, and a higher
number were downregulated in the CNTF-based treatment
compared to FBS-based treatment (Figure 4D). Most genes
that were upregulated in the CNTF-based treatment were also
upregulated in the FBS-based treatment (Figure 4D).
Identification  of  genes  exhibiting  significant  changes  in
expression level: After the behavior of gene expression levels
Figure 2. Treatment conditions can be distinguished based on changes in global gene expression using principal component analysis (PCA).
A: Principal components were calculated for each the three treatments (red=ciliary neurotrophic factor [CNTF), green=fetal bovine serum
[FBS], blue=standard medium [SM]). Data from each of these treatments shows considerable separation from the other two, with CNTF and
SM at the two extremes. B: A Venn Diagram showing significant genes (|fold change|>2, false discovery rate [FDR] α<0.05) unique to either
CNTF or FBS treatments (normalized to SM), as well as those genes significantly expressed in both treatments. The top number in each piece
is the total gene count in that area, and the numbers below indicate the number of those genes that are upregulated and downregulated.
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1489overall was examined, specific genes were identified, and how
their  expression  was  influenced  by  the  differentiation
conditions  employed  was  considered.  Among  the  known
genes in the pig genome, those relating to signal transduction
pathways,  gene  transcription,  and  cell  cycle  control  were
selected for individual inspection (Appendix 2). The genes
listed met our chosen significance criteria (|fold change| >2,
FDR α<0.05) for the CNTF-based treatment condition, and
were then compared further. Most of the genes listed related
to the cell cycle were downregulated with differentiation,
whereas those related to cell signaling, particularly of the Wnt
pathway,  were  upregulated.  Markers  for  the  three  mature
neural  progenitor  lineages,  namely,  neurons  (doublecortin
[DCX],  tubulin,  beta  3  [TUBB3],  neurofilament  light
polypeptide [NEFL]), astrocytes (aquaporin 4 [AQP4], glial
fibrillary  acidic  protein  [GFAP]),  and  oligodendrocytes
(myelin basic protein [MBP]) were upregulated (Appendix
2). Genes related to the development of neural circuitry were
also upregulated, including axonal projections (ephrin type-A
receptor 4 [EPHA4], roundabout homolog 1 [ROBO1]) and
synaptic function (synaptic vesicle 2-related protein [SVOP],
synaptoporin [SYNPR], synaptotagmin-1 [SYT1]; Appendix
2).  Certain  immune-related  genes  were  also  upregulated,
including  several  MHC  class  II  antigens  and  one  class  I
antigen, interleukins and IL receptors (IL-7R, IL-13Ra, and
IL-16), several other surface molecules (cluster differentiation
[CD14], CD74, CD180), and Toll-like receptor 2 (TLR2).
Each gene symbol is colored based on its location in the
hierarchical clusters in Figure 3, of which most upregulated
genes correlate to the blue cluster, and most downregulated
correlate to the green cluster.
Confirmation  of  clustering  by  treatment  condition  using
quantitative real-time polymerase chain reaction: In addition
to  the  microarray  results,  selected  immature  and  lineage-
related genes were analyzed using quantitative real-time PCR.
The  results  were  further  subjected  to  cluster  analysis
employing  Pearson’s  correlation  coefficient  as  a  distance
measure (Figure 5). Results showed an evident trend toward
clustering  by  treatment  group,  with  only  one  of  the  nine
groups  countering  the  trend.  On  closer  examination,  that
particular case involved the untreated (SM) group at day 5
associating with the FBS group at day 1, perhaps reflecting a
degree of spontaneous differentiation in the former vis-à-vis
relatively  modest  treatment-induced  changes  in  the  latter.
Apart from those two cases, there was also a trend for clusters
to order according to time point (treatment day). In terms of
individual  gene  categories,  there  was  clustering  of  the
progenitor markers nestin, vimentin, and Krüppel-like factor
4 (KLF4) across treatments and time points, as there was for
the oligodentrocyte markers myelin basic protein (MBP) and
claudin 11. Pathway genes Jak1 and Stat3 associated most
closely with Sox2 and CXCR4, while STAT1 clustered with
the astrocyte-associated marker GFAP.
Changes across a gene expression profile with quantitative
real-time polymerase chain reaction: The expression of 15
transcripts was determined with quantitative real-time PCR,
and the results obtained from cells cultured under proliferation
conditions were compared to those from cells cultured under
Figure 3. Heat map analysis revealed
that  the  5,666  genes  exhibiting
statistically  significant  changes  in
expression  level  (false  discovery  rate
[FDR] α<0.05) could be clustered into
one of four groups. Genes from the Jak/
STAT, Wnt, and Notch pathways are
shown  relative  to  positioning  in  the
relevant clusters, along with arrows next
to each gene name indicating if the gene
is  upregulated  or  downregulated.
Asterisk  (*)  indicates  significant  fold
change (|fold change|>2).
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1490differentiation  conditions.  After  normalization  to  the
expression levels of untreated controls at day 0, differential
expression was compared for cells undergoing the CNTF- and
FBS-based treatments and compared to the cells maintained
in  SM  over  the  identical  period.  Comparison  of  overall
expression changes across all genes analyzed showed modest
variability in gene expression for the SM-treated group, with
the exception of higher MBP expression at day 5 (Figure 6A).
Interestingly, this could have contributed to the clustering
anomaly noted in Figure 5, especially taken together with the
relative lack of GFAP induction at day 1 for the FBS group.
Looking at treatment condition, several genes showed very
large  fold  changes  across  time  following  CNTF-based
treatment, as claudin 11, MBP, and GFAP all trended to higher
expression levels with time (Figure 6B). FBS-treated cells
showed higher GFAP expression, particularly beyond day 1,
with comparatively restrained changes in other genes (Figure
6C).
Quantitative  changes  in  porcine  neural  progenitor  cell
transcripts under differentiation conditions: The profile of 15
markers  was  then  examined  by  individual  gene  for  each
treatment  condition  and  treatment  day.  The  progenitor
markers included nestin, Sox2, and vimentin, together with the
proliferation  marker  Ki-67  (Figure  7A-D).  Significant
downregulation of nestin expression was observed for the
CNTF (up to approximately fourfold, transcript levels: d1,
0.74; d3, 0.37; d5, 0.25), and FBS (approximately 1.6 fold,
transcript  levels:  d1,  0.79;  d3,  0.66;  d5,  0.66)  treatment
conditions,  compared  to  matched  controls  cultured  under
standard  proliferation  conditions  (Figure  7A).  In  contrast,
Sox2 was upregulated in response to either CNTF or FBS
treatment (Figure 7B), although more obviously for the CNTF
group. Of note, in each case the response was most prominent
at day 1 of treatment and rapidly diminished on subsequent
days. Vimentin was generally upregulated across the control
and treatment groups compared to the baseline controls from
day 0, indicating a time-related shift toward greater vimentin
expression during the culture period. Compared to the time-
matched untreated controls, however, vimentin was generally
downregulated in the CNTF-based and FBS-based treatment
groups, although day 1 in FBS was transiently higher (Figure
7C). Ki-67 showed modest upregulation in the CNTF-based
treatment condition, whereas this was not observed for the
FBS condition (Figure 7D). In both cases, Ki-67 expression
appeared to trend downward with time.
Samples  from  the  same  treatment  groups  were  also
analyzed for the expression of five differentiation markers
(β3-tubulin,  Map2,  MBP,  claudin  11,  GFAP).  These  data
revealed evidence of mixed neuronal and glial differentiation
associated with both treatment populations (Figure 7E-I). The
neural marker β3-tubulin was only modestly altered, being
slightly upregulated (1.1–2.2 fold) in the CNTF and FBS
groups  (Figure  7E).  In  contrast,  there  were  notable
(>threefold) increases in message for the mature neuronal
Figure  4.  The  use  of  volcano  plots
allows  for  comparison  between
conditions.  Volcano  plot  displays  of
genes  significantly  upregulated  and
downregulated as a result of different
treatments:  A:  Ciliary  neurotrophic
factor (CNTF)-based conditions using
standard medium (SM) as baseline, (B)
fetal  bovine  serum  (FBS)-based
conditions using SM as baseline, and
(C) CNTF using FBS as baseline (C).
With  an  false  discovery  rate  (FDR)
multiple test correction of α<0.05, the p-
value cutoff (indicated by red dashed
line) was p<.00794424 in (A) and (B),
and was p<0.00554170 in (C). The lines
drawn at −1 and 1 show the log2 cutoff
for significant fold change in A-C. D:
Comparison  of  significantly  changed
genes for CNTF and FBS treatments,
using SM as a control in both cases. The
box in (D) is the log2 cutoff for fold
change significance. The colors of the
data  points  correspond  to  the
hierarchical cluster analysis in Figure 3
and therefore illustrate the direction of
expression changes for genes in those
clusters, relative to treatment condition.
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1491marker MAP2 in response to the CNTF condition across time
points together with a substantial, but lower, response in the
FBS condition that returned to control levels at the latest time
point (Figure 7F). Two oligodendrocyte markers, MBP and
claudin 11, were among the two most dramatically altered
transcripts in the study, with MBP upregulated more than 88
fold in the CNTF condition at day 5, along with claudin 11,
which increased 32 fold. Both transcripts increased only two-
to fourfold in the FBS condition (Figure 7H,I). The glial
marker GFAP was also notably upregulated, increasing more
than 23 fold in the CNTF condition and greater than 26 fold
in the FBS condition by the final time point (Figure 7G).
Two nuclear transcription factors related to proliferation
were also examined. Expression of KLF4, a member of the
Krüppel-like  family  of  transcription  factors,  was  strongly
decreased up to fivefold (transcript level approximately 0.2)
in the CNTF and FBS treatment conditions (Figure 7J). Of the
transcripts tested, KLF4 was the most strongly downregulated
in response to differentiation conditions. Transcripts for c-
Myc were also downregulated, but only in the FBS condition
(Figure 7K).
In addition, transcripts levels for the chemokine receptor
CXCR4, which is associated with cell homing behavior, were
strongly increased (up to 5.9 fold) in the CNTF- and FBS-
based treatment conditions (Figure 7L). These elevated levels
peaked on day 1 and exhibited a clear downward trend over
the remainder of the treatment period. Finally, the signaling
pathway genes Jak1, STAT1, and STAT3 were also examined,
and  they  were  upregulated  in  the  CNTF-  and  FBS-based
treatment conditions to varying degrees (Figure 7M-O).
Validation of the microarray data via quantitative real-time
polymerase chain reaction: The results of the quantitative
Figure 5. Expression patterns of selected
genes  were  confirmed  using
quantitative real-time polymerase chain
reaction  (PCR).  Confirmation  of
selected  immature  and  lineage-related
genes was undertaken using quantitative
real-time PCR and displayed as a global
view  heat  map  across  treatment
conditions and time points in culture, the
latter indicated along the abscissa. As
indicated by the group labels, all porcine
neural  progenitor  cultures  were
originally derived from brain tissue at
embryonic  day  45  (E45-pBPC).
Untreated  controls  (standard  medium
[SM]) have titles in green text, ciliary
neurotrophic  factor  (CNTF)  treatment
in red, and fetal bovine serum (FBS) in
blue. The results were further subjected
to cluster analysis employing Pearson’s
correlation  coefficient  as  a  distance
measure, as indicated by dendrograms at
top  and  left.  For  the  heat  map  scale
(right), black is set as the median of all
ΔCT values (23) obtained in the study,
while  increasing  intensity  of  red
represents higher gene expression levels
and  increasing  green  shows  lower
levels.
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1492Figure 6. Genes were examined during the time course of treatment using real-time polymerase chain reaction (PCR). Fifteen genes were
profiled across five days following treatment with either standard medium (SM, A), ciliary neurotrophic factor (CNTF; B), or fetal bovine
serum (FBS; C). Fold changes in expression level were calculated with RQ using the ΔΔCt method, normalized to SM day 0. Samples were
run in triplicate and both CNTF and FBS conditions were compared to the respective SM data for days 1, 3 and 5, with significance established
using the Student’s t-test. Error bars represent standard error of the mean (SEM). *=p<0.05.
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1493Figure 7. Examination of 15 selected gene expression profiles using polymerase chain reaction (PCR) shows significant changes with treatment
and time. Progenitor markers nestin (A), Sox2 (B), Vimentin (C), Ki-67 (D), Krüppel-like factor 4 (Klf4; J), c-myc (K), and C-X-C chemokine
receptor type 4 (CXCR4; L) are profiled across time for each treatment. Mature neural markers β3-tubulin (E) and Map2 (F) as well as mature
glial markers glial fibrillary acidic protein (GFAP; G), myelin basic protein (MBP; H), and Claudin 11 (I) are profiled as well. Changes to
gene expression relating to the Jak-STAT signaling pathway, Janus kinase 1 (Jak1; M), signal transducer and activator of transcription 3
(STAT1; N) and signal transducer and activator of transcription 3 (STAT3; O), are also shown. Fold changes for the 15 gene profiles were
normalized to standard medium (SM) day 0. Data from treatment day 1 are shown as red bars, day 3 as green bars, and day 5 as blue bars.
Both fetal bovine serum (FBS) and ciliary neurotrophic factor (CNTF) treated groups are compared to SM, respective to time point, and then
significance was established using the Student’s t-test. Error bars represent standard error of the mean (SEM). *=p<0.05. β-Actin was used
as the endogenous control.
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1494real-time PCR analysis were used to validate the microarray
data (Table 2). For the CNTF-based treatment group, the data
sets showed similar trends. Examined in detail, however, the
microarray  data  for  β3-tubulin,  CXCR4,  GFAP,  and  Jak1
exhibited variance regarding the quantitative real-time PCR
results across treatment groups.
Protein  expression  examined  using  immunocytochemistry:
Immunocytochemistry was used to confirm marker changes
at the level of protein expression for the CNTF and FBS
treatment conditions, as well as to examine the distribution of
labeling  for  specific  markers  within  the  cultured  cell
population. After 24 h, the immature markers Sox2, Ki-67
(Figure 8A,B), and Klf4 (Figure 8F), the lineage markers β3-
tubulin, Map2, and GFAP (Figure 8C,D,E), and the surface
marker CXCR4 (Figure 8G) were evaluated in treated cultures
and untreated controls (see also Figure 9). To do this, the
percentage of immunopositive cells was calculated for each
marker under each condition. Of the immature markers, KLF4
was  most  closely  associated  with  decreased  expression,
consistent  with  loss  of  progenitor  status.  Of  the  neuronal
markers,  Map2  was  equally  upregulated  under  both
differentiation conditions, whereas β3-tubulin appeared to be
increased over baseline only in the CNTF condition. The glial
marker  GFAP  was  expressed  by  a  similarly  sized
subpopulation of cells across conditions, although the labeling
intensity was more prominent in the differentiating cultures,
suggesting increased expression levels. CXCR4 labeling also
increased in differentiating cultures, more so in the CNTF
condition.
DISCUSSION
The pig has recently emerged as a valuable large animal model
for use in experimental medicine, particularly in situations
where  rodent  models  do  not  adequately  represent  the
challenges faced when translating new interventions to the
clinical setting. Stem cell technology is one field in which
results in rodents often need to be reproduced on a larger scale,
using  techniques  suitable  for  human  application.  Due  to
immunological considerations, the essential starting point for
work  in  stem  cell  transplantation  is  deriving  and
characterizing  allogeneic  cells.  Despite  the  obstacles
presented  by  working  with  large  animals,  there  has  been
recent progress culturing stem cell populations from porcine
tissue, including proliferation-competent progenitors from the
brain  [31,33,41]  and  neural  retina  [32,33].  Although
molecular analysis of these porcine CNS progenitors has been
somewhat constrained by a lack of species-specific probes,
ongoing sequencing of the Sus scrofa genome now permits
the  design  of  porcine  microarrays  as  well  as  pig-specific
primers for use in quantitative real-time PCR analysis. The
present study takes advantage of these new tools and shows
for the first time the magnitude and temporal characteristics
of  the  transcriptional  response  of  porcine  forebrain
progenitors following exposure to differentiation conditions
in culture. Several changes seen have implications for the
tolerance and integration of grafted pNPCs.
In this study, two alternate conditions were tested, both
commonly  used  for  in  vitro  determination  of  NPC
multipotency. The methods differ with one being defined in
terms of chemical composition (CNTF) and the other (FBS)
undefined.  Both  were  associated  with  changes  in  gene
expression consistent with the induction of differentiation in
pNPCs, including the downregulation of immature markers
and the upregulation of lineage markers, thereby confirming
previous studies reporting in vitro differentiation of these
cells. In addition, this study confirms at the transcriptional and
protein levels the upregulation of markers reflecting neuronal
and glial subpopulations within the differentiating cultures, as
previously indicated by immunolabeling alone [31,32] and
extends those findings by delineating the relative magnitude
and temporal characteristics of the changes in a manner that
allows comparison between treatment conditions. From this
it was evident that the overall pattern of change seen across
the transcription profile was largely similar between treatment
groups and that the major difference was magnitude of effect.
Specifically, although both treatments resulted in elevated
markers  for  neuronal  and  glial  lineage,  the  CNTF-based
treatment condition showed quantitatively greater expression
of the neuron- and glial-associated markers MBP, claudin 11,
and  Map2,  together  with  greater  induction  of  the  neural
migration-associated marker CXCR4, whereas the FBS-based
treatment  condition  resulted  in  greater  induction  of  the
astrocyte-associated marker GFAP. These findings support
the concept that use of defined, serum-free differentiation
conditions  confers  advantages  over  serum  in  terms  of
promoting the relative yield of cells with neuronal phenotype.
In previous work, we investigated the transcriptome of
porcine NPCs using a human microarray [31]. In the current
study, we present the results of what is, to our knowledge, the
first  investigation  of  brain-derived  pNPCs  using  porcine-
specific microarrays, as well as the first examination of global
changes in the pNPC transcriptome during differentiation.
The results obtained reveal the identity and relative proportion
of transcripts being upregulated and downregulated over the
course of in vitro differentiation, together with a comparison
between non-defined (FBS) and defined (CNTF) conditions.
These results confirm the differentiating properties of both
conditions, while also confirming that the CNTF condition is
the more favorable of the two for relative yield of neuronal
phenotype.
The  data  also  bring  to  attention  several  additional
interesting  features  and  novel  findings  for  the  changes
observed. Given the evidence in favor of the differentiating
qualities of the CNTF condition, the involvement of the Jak/
STAT,  Wnt,  and  Notch  pathways,  as  illustrated  in  the
hierarchical  cluster  analysis,  is  consistent  with  cellular
Molecular Vision 2012; 18:1484-1504 <http://www.molvis.org/molvis/v18/a155> © 2012 Molecular Vision
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1496differentiation. For instance, the Jak/STAT pathway has been
shown to initiate astrogliogenesis [42] in a CNTF-dependent
manner [43] and, through STAT5, to induce proliferation of
NPCs [44], consistent with the results obtained here. Wnt 4
and  Wnt  5B  have  been  previously  implicated  in  NPC
differentiation  [45].  Wnt  10B  has  been  implicated  in
differentiating epithelial stem cells in the skin [46] and might
also play a role in differentiating NPCs, as this Wnt gene was
also significantly upregulated in the present study. Dkk-1, an
inhibitor  of  the  Wnt  pathway,  has  been  implicated  in
differentiating ES cells into NPCs [47]. In terms of the Notch
pathway, Notch 2 and 3 have been shown to be upregulated
in the developing brain [48]. Hes6 has been shown to inhibit
astrocyte formation and favor neurogenesis in NPCs [49].
Hey1 aids in maintaining NPCs in the developing brain [50],
and here was more altered by the FBS treatment condition.
Differentiation is a predominant theme evident in the
gene expression changes seen under the conditions employed
Figure 8. Changes in protein expression were identified using immunocytochemical analysis. Expression of seven selected markers were
confirmed as proteins. Markers examined included Sox2 (A), Ki-67 (B), β3-tubulin (C), Map2 (D), glial markers glial fibrillary acidic protein
(GFAP; E), Krüppel-like factor 4 (KLF4; F), and C-X-C chemokine receptor type 4 (CXCR4; G). Insets provide higher power images of
labeled profiles to illustrate labeling patterns. Photomicrographs showing labeling for each marker under standard medium (SM), ciliary
neurotrophic factor (CNTF), and fetal bovine serum (FBS) conditions from left to right, respectively. Insets in F and G provide higher power
images of labeled profiles, to illustrate labeling patterns. In addition, results after 24 h treatment were compared across treatment conditions
as shown in the accompanying histograms. In each case, untreated cultures in SM are represented by the left bar, the CNTF-based condition
by the center bar, and the FBS-based condition by the right bar. Error bars show standard deviation (SD); asterisks (*) denote statistical
significance (p<0.05). Scale bar: 100 µm.
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1497Figure 9. Changes in selected marker proteins showing changes in relative expression levels for each treatment condition. This figure expands
on the immunocytochemical data presented in Figure 8 by showing the results obtained for the same seven markers under baseline proliferation
(standard medium [SM]) conditions (A, D, G, J, M, P, S), as previously shown, together with the ciliary neurotrophic factor (CNTF; B, E,
H, K, N, O, T) and ftela bovine serum (FBS; C, F, I, L, O, R, U) treatment conditions for comparison. Markers are listed to the left of the
data, treatment above. Scale bar: 100 µm.
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1498here, and several markers associated with immune function
also show significant upregulation, particularly in response to
CNTF-based treatment. Of these, among the most prominent
are the MHC class II antigens (Appendix 2). There have been
prior  reports  of  upregulation  of  these  antigens  by
differentiating cells [51]. MHC class II upregulation has been
shown to be induced by related ligands such as LIF and by
activation  of  the  Jak/STAT  pathway,  particularly  through
upregulation  of  the  STAT1  gene  [52].  Importantly,  any
changes in MHC class II expression represent an important
consideration in the context of NPC transplantation and graft
tolerance. Other immune-related genes upregulated following
CNTF  treatment  include  several  interleukins,  specifically
interleukin 7 receptor (IL-7R) and interleukin 16 (IL-16).
Interleukin 7 may play a trophic role during differentiation in
the developing brain [53], for instance, in glial development
[54]. Interleukin 16 may also have a role in the developing
brain, particularly in microglial activation [55].
Other upregulated genes with putative relationships to
neurogenesis include TLR2 and bone morphogenetic protein
2. Bone morphogenetic protein 2 has been reported to induce
neurogenesis in NPCs [56], and TLR2 has been implicated in
neurogenesis in the adult murine hippocampus [57]. Both
signaling-related  molecules  may  relate  to  the  preferential
generation  of  neurons  seen  in  the  CNTF-based  treatment
condition.
A different aspect of the data that merits consideration is
the dynamic pattern of changes seen in transcript expression.
One important observation from the quantitative real-time
PCR data are that the expression of some transcripts varied in
control  pNPCs  maintained  under  standard  proliferation
conditions for the five-day course of the experiment. This
finding reveals variability in gene expression that is not a
direct function of treatment condition and points out the value
of using time-matched as well as baseline controls in studies
of this type. This finding also implies that changes up to
approximately twofold should be interpreted with caution for
any given gene since this might reflect factors unrelated to
treatment condition.
Another interesting feature of the temporal pattern relates
to whether transcript expression level amplifies with time or
peaks early and then trends back toward control levels. In the
present study, an example of the first pattern is represented by
GFAP, which trended upward with duration of treatment. In
addition, nestin trended downward for the CNTF condition.
In contrast, an example of an abrupt change in transcript
expression that subsequently decelerated back in the direction
of control levels is represented by CXCR4, together with Sox2
for CNTF and MAP2 for FBS. The former, amplifying pattern
would appear to reflect transcriptional changes of a more
sustained nature as might be anticipated for marker changes
associated  with  terminal  differentiation.  The  latter,  more
transient, pattern might reflect short-term reactive responses
to altered culture conditions. The transient quality of CXCR4
expression, a receptor involved in stem cell homing, is of
particular interest in that it has potential implications for the
timing of transplantation and successful integration of grafted
cells.
Considering specific markers, the present data support
the use of nestin as a marker of relative immaturity for porcine
NPCs, as shown in other species, specifically in preference to
the  other  neural  progenitor  markers  vimentin  and  Sox2.
Likewise, the lineage markers MBP, claudin 11, MAP2, and
GFAP were notably responsive to treatment conditions, as
anticipated from prior work. Also examined here were two
markers  less  frequently  monitored,  namely,  KLF4  and
CXCR4, and expression of these genes exhibited prominent
treatment-associated effects at the RNA and protein levels.
KLF4 is a zinc finger transcription factor involved in diverse
cell functions, including proliferation [58], differentiation,
and  apoptosis  [59,60].  Recently,  KLF4  has  received
considerable attention as one out of a set of four transcription
factors  whose  combined  overexpression  is  sufficient  to
reprogram  mouse  and  human  fibroblasts  into  induced
pluripotent stem cells [61,62]. Since KLF4 overexpression
can obviously contribute to increased phenotypic plasticity, it
is perhaps not surprising that the induction of differentiation,
which involves phenotypic restriction, would be accompanied
by decreased transcription of this gene. What was particularly
striking is that KLF4 decreased more abruptly at the transcript
and  protein  levels  than  did  other  markers  of  immaturity.
Therefore,  knowing  whether  diminished  KLF4  expression
represents  a  novel  and  sensitive  indicator  of  the  loss  of
progenitor status during the differentiation of NPCs would be
interesting.
In contrast, expression of the CXC chemokine receptor 4
(CXCR4, fusin, CD184) was rapidly and strongly elevated in
response  to  the  CNTF-based  and  FBS-based  treatment
conditions. Multiple cell types in the mammalian brain have
been shown to possess chemokine receptors [63], including
the expression of CCR3, CXCR4, CXCR2, and CX3CR1 on
neurons, CXCR4 on astrocytes, and CCR3 and CCR5 on
microglia. Stromal cell-derived factor-1 (SDF-1) is known to
serve as a ligand for CXCR4, and this signaling pathway has
a documented role in mediating cell migration, precursor cell
proliferation, and neuronal circuit formation during neural
development  and  is  possibly  involved  in  regulating  cell
migration in response to injury [34,64–67]. In previous work,
we reported expression of SDF-1, and tentatively CXCR4, by
porcine NPCs [31] as well as expression of CXCR4 by feline
NPCs [68]. In those instances, the NPCs were maintained
under proliferation conditions. Here we extend those findings
by  demonstrating  significant  upregulation  of  CXCR4
expression under CNTF and FBS differentiation conditions,
suggesting a role for this surface receptor during the transition
from multipotent neural progenitor to committed precursor.
This  developmental  time  window  also  corresponds  to  the
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1499period of active cell migration during neurogenesis in the
mammalian CNS. The transient quality of CXCR4 expression
during differentiation has potential implications for the timing
of transplantation and successful integration of grafted cells.
Previous differentiation studies involving rat and mouse
retinal progenitor cells (RPCs) presented results comparable
in aspects to our current pig study. Rat RPCs were studied by
Bhattacharya et al. [24] who looked at pathways involved in
differentiation, particularly the Jak/STAT, MAPK, and Notch
pathways. The researchers found an increase in the protein
levels of Notch 1 and Hes5 following CNTF treatment, while
our  porcine  brain  cells  did  not  show  an  increase  in  the
respective mRNA levels of those particular genes. The mouse
RPC study by Rhee et al. [21] included a microarray analysis
of gene transcript levels following CNTF treatment. Several
of the gene expression changes Rhee et al. list are mirrored in
the present study, although here the changes did not reach our
significance criteria, such as synapsin II, nucleolin, annexin
A7, ephrin-B2, STAT1, and STAT3.
The present study contributes to the small but growing
literature on porcine NPC differentiation and confirms some
previous findings [36,69] while also introducing several novel
observations.  Differences  between  studies  might  reflect
methodological  differences  including  the  details  of  the
treatment  conditions  used,  as  well  as  the  preferential
examination of transcript expression, as opposed to proteins.
In a proteomics study, Skalnikova et al. [36] reported gene
expression  changes  for  α-centractin,  α-B  crystalline,  and
mitochondrial  medium-chain  specific  acyl-CoA
dehydrogenase  that  were  similar  in  direction  to  what  we
observed with microarray, although they did not meet our
significance criteria. Some of the genes Skalnikova et al.
reported as being upregulated, including heat-shock protein
β-1 and hnRNP H, were not corroborated by our transcript-
based data. In terms of pathway analysis, we found several
genes with fold changes similar to their findings, including
Alk, cJun, CaMKIIα, ERK5, JNK, and CASP1, although only
CASP1 reached significance here. At least some of these
genes may play a role in non-specific responses to stress, and
therefore the data may in part reflect differences in laboratory
protocols.
In general terms, the present study provides additional
evidence of the extent to which molecular findings related to
neural progenitor cell behavior can be extended from rodents
to a large animal model, in this case the pig. Such models have
importance in translational research, particular for surgical
approaches  at  the  organ  level.  The  present  results  also
reinforce our previous findings for murine retinal progenitors
and reveal a similar pattern of differentiation as a function of
CNTF-based, versus serum-based, treatment. Together, these
results  are  consistent  with  a  broad  conservation  in
differentiation  characteristics  between  CNS  progenitor
populations across mammalian species, a notion that has been
often  been  assumed  but  only  recently  examined  more
systematically. Significantly, the present work also reveals
short-term dynamics in transcript levels, relevant to timing of
phenotypic  assays  and  suggestive  of  complexities  in  the
regulatory  process  occurring  during  NPC  differentiation
worthy of further investigation. In particular, the abrupt and
substantial changes seen in KLF4 and CXCR4 expression at
the transcript and protein levels suggest that regulation of
these  genes  is  sensitive  to  changes  occurring  during  the
transition of NPCs from multipotent progenitors to specified
post-mitotic precursors. Furthermore, upregulation of MHC
genes can result from various culture conditions, including
differentiation treatments, and this should be considered when
interpreting the results of transplantation studies, particularly
regarding graft tolerance.
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1503Appendix 1. Classes of genes expressed in each hierarchical cluster.
Genes from the cluster analysis shown in Figure 3 were
subjected to DAVID to determine the types of genes expressed
in each of the four hierarchical clusters. Entries shown were
selected when p<0.05. To access the data, click or select the
words “Appendix 1.” This will initiate the download of a
compressed (pdf) archive that contains the file.
Appendix 2. Significant genes of interest from the microarray analysis.
Selected genes met significance criteria (|fold change| >
2; FDR α<0.05) for CNTF treatment with SM as a control.
These genes were then analyzed for their fold changes in the
FBS group with SM as a control and again in CNTF with FBS
as a control. The background color for each gene symbol cell
corresponds to the location of the gene in the hierarchical
cluster analysis presented in Figure 3. Asterisk (*) denotes
significant fold change for that treatment comparison (|fold
change| > 2; FDR α<0.05). To access the data, click or select
the words “Appendix 2.” This will initiate the download of a
compressed (pdf) archive that contains the file.
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